157.47
price up icon2.31%   3.56
after-market Dopo l'orario di chiusura: 157.47
loading

Johnson Johnson Borsa (JNJ) Ultime notizie

pulisher
05:11 AM

Johnson & Johnson: 15% of AI Use Cases Deliver 80% of Value - PYMNTS.com

05:11 AM
pulisher
03:08 AM

Jim Cramer on Johnson & Johnson (JNJ): Tariff-Proof, Drug-Driven, and Still a Buy - Yahoo Finance

03:08 AM
pulisher
02:51 AM

Grego and Johnson on College Baseball Foundation Award Watch Lists - Ball State University Athletics

02:51 AM
pulisher
11:17 AM

Johnson & Johnson's Role in Strengthening Mexico and North America's Healthcare Ecosystem - U.S. Chamber of Commerce

11:17 AM
pulisher
08:39 AM

Crime is nonpartisan and the blame game on crime in cities is wrong – on both sides - The Conversation

08:39 AM
pulisher
07:00 AM

Johnson & Johnson Pivots Its AI Strategy - WSJ

07:00 AM
pulisher
Apr 17, 2025

T&F to Host 2025 Michael Johnson Invitational Over Weekend - baylorbears.com

Apr 17, 2025
pulisher
Apr 17, 2025

How To Put $100 In Your Retirement Fund Each Month With Johnson & Johnson Stock - Yahoo Finance

Apr 17, 2025
pulisher
Apr 17, 2025

Minium: Sofia Johnson Chose ODU Sight Unseen, And The Monarch Tennis Star Is So Glad She Did - Old Dominion Athletics

Apr 17, 2025
pulisher
Apr 17, 2025

Lawyers seek second chance from Texas judge in Johnson & Johnson’s talcum case - Dallas News

Apr 17, 2025
pulisher
Apr 17, 2025

Johnson & Johnson (JNJ): Among the Innovative Healthcare Stocks to Watch in 2025 - Yahoo Finance

Apr 17, 2025
pulisher
Apr 17, 2025

Val Chmerkovskiy Admits Finding Time for Intimacy with Wife Jenna Johnson Is 'Hit or Miss' at Times (Exclusive) - People.com

Apr 17, 2025
pulisher
Apr 17, 2025

Clacton: Three missing teens safeguarded from drug line - Essex Police

Apr 17, 2025
pulisher
Apr 17, 2025

The Senate – A look at how Thune and Schumer are doing - Punchbowl News

Apr 17, 2025
pulisher
Apr 17, 2025

Spadaro: Paying it forward is the Eagles' Way - Philadelphia Eagles

Apr 17, 2025
pulisher
Apr 17, 2025

4 Reasons Johnson & Johnson Could Be the Perfect Stock to Own in Today's Turbulent Market - The Motley Fool

Apr 17, 2025
pulisher
Apr 17, 2025

Furr, Johnson Added Women’s Basketball Staff - Arkansas Razorbacks

Apr 17, 2025
pulisher
Apr 16, 2025

Men's Tennis: Cadets sweep VTSU Johnson for second time this season, strengthen hopes for Empire 8 Tournament berth - Norwich University Athletics

Apr 16, 2025
pulisher
Apr 16, 2025

Which Colleen Hoover Books Are Becoming Movies? 'Verity' And More - Deadline

Apr 16, 2025
pulisher
Apr 16, 2025

J&J’s electrophysiology sales dip amid slow Varipulse start - MedTech Dive

Apr 16, 2025
pulisher
Apr 16, 2025

A dozen House Republicans fire warning shot to Mike Johnson on Medicaid cuts - Axios

Apr 16, 2025
pulisher
Apr 16, 2025

Our culture of inclusion - Johnson & Johnson

Apr 16, 2025
pulisher
Apr 16, 2025

Grassley, Johnson press DOJ IG to respond on whether ‘untasked’ undercover agents were present on Jan 6 - Fox News

Apr 16, 2025
pulisher
Apr 16, 2025

Jim Cramer: Johnson & Johnson (JNJ) Is a “Great American Company with a AAA Balance Sheet” - Yahoo Finance

Apr 16, 2025
pulisher
Apr 16, 2025

Trump’s Tariff Threat for Drug imports Poses Big Political Risks - The New York Times

Apr 16, 2025
pulisher
Apr 16, 2025

EPO meets with Johnson & Johnson - epo.org

Apr 16, 2025
pulisher
Apr 16, 2025

Katherine Johnson | Biography, Education, Accomplishments, & Facts - Britannica

Apr 16, 2025
pulisher
Apr 15, 2025

Obituary for Ken Johnson - Harvey Anderson & Johnson Funeral Home

Apr 15, 2025
pulisher
Apr 15, 2025

The Atlantic Hires Jenna Johnson and Dan Zak as Senior Editors, and Tyler Austin Harper as Staff Writer - The Atlantic

Apr 15, 2025
pulisher
Apr 15, 2025

Dow Giant Flexes With A Guidance Hike Despite Tariff Worries - Investor's Business Daily

Apr 15, 2025
pulisher
Apr 15, 2025

Johnson & Johnson earnings beat estimates on strong cancer drug sales - The Economic Times

Apr 15, 2025
pulisher
Apr 15, 2025

Johnson & Johnson (JNJ): Stuck in a Range but Ready to Break Out if Legal Clouds Clear – Jim Cramer Weighs In - Yahoo Finance

Apr 15, 2025
pulisher
Apr 15, 2025

Johnson & Johnson estimates $400M impact from worldwide tariffs, largely in medtech - Fierce Biotech

Apr 15, 2025
pulisher
Apr 15, 2025

Johnson & Johnson (NYSE:JNJ) Increases Dividend and Reports Strong Q1 Earnings Growth - Yahoo Finance

Apr 15, 2025
pulisher
Apr 15, 2025

LEGACY IN FOCUS: Whitney Johnson, Women's Basketball - Morgan State University Athletics

Apr 15, 2025
pulisher
Apr 15, 2025

Johnson & Johnson Earnings: Solid Innovation and Manageable Tariff Headwind - Morningstar

Apr 15, 2025
pulisher
Apr 15, 2025

Johnson & Johnson expects $400M in tariff costs this year - MassDevice

Apr 15, 2025
pulisher
Apr 15, 2025

Johnson & Johnson warns pharma tariffs could cause drug shortages - Financial Times

Apr 15, 2025
pulisher
Apr 15, 2025

Negative effects of technology: Psychological, social, and health - Medical News Today

Apr 15, 2025
pulisher
Apr 15, 2025

J&J pegs tariff costs at about $400M in 2025 - MedTech Dive

Apr 15, 2025
pulisher
Apr 15, 2025

Johnson & Johnson expects $400 million in tariff-related costs, mostly related to China - 5 EYEWITNESS NEWS

Apr 15, 2025
pulisher
Apr 15, 2025

J&J beat on earnings, but tariffs still pressure pharma sector - Yahoo Finance

Apr 15, 2025
pulisher
Apr 15, 2025

J&J completes first surgeries with Ottava robot - MedTech Dive

Apr 15, 2025
pulisher
Apr 15, 2025

J&J keeps forecasts steady as pharma confronts tariff threat - BioPharma Dive

Apr 15, 2025
pulisher
Apr 15, 2025

As Johnson & Johnson navigates changing tariff landscape, execs lay out their expectations - Fierce Pharma

Apr 15, 2025
pulisher
Apr 15, 2025

Johnson & Johnson CEO warns US tariffs may disrupt drug supply - Reuters

Apr 15, 2025
pulisher
Apr 15, 2025

Why Johnson & Johnson Stock Is Down After Earnings Beat Expectations - Barron's

Apr 15, 2025
pulisher
Apr 15, 2025

Digital Marketing Grad Makes Data-Driven Decisions at Johnson & Johnson - Full Sail University

Apr 15, 2025
pulisher
Apr 15, 2025

Stocks making the biggest moves premarket: Bank of America, Boeing, Johnson & Johnson and more - CNBC

Apr 15, 2025
pulisher
Apr 15, 2025

Johnson & Johnson Tops Earnings Estimates and Boosts Outlook. The Stock Slips. - Barron's

Apr 15, 2025
pulisher
Apr 15, 2025

Johnson & Johnson Reports Q1 2025 Results - BioSpace

Apr 15, 2025
pulisher
Apr 15, 2025

Johnson & Johnson Announces 63rd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.8% - BioSpace

Apr 15, 2025
pulisher
Apr 15, 2025

Tax policy key to building US manufacturing, says Johnson & Johnson CEO - MarketWatch

Apr 15, 2025
pulisher
Apr 15, 2025

Johnson & Johnson Tops Q1 Estimates, Lifts Full-Year Sales Outlook - Investopedia

Apr 15, 2025
pulisher
Apr 15, 2025

What you need to know about Johnson & Johnson’s 2025 first-quarter earnings - Johnson & Johnson

Apr 15, 2025
pulisher
Apr 15, 2025

J&J beats Wall Street quarterly sales and profit estimates on cancer drug sales - Yahoo Finance

Apr 15, 2025
pulisher
Apr 15, 2025

Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace

Apr 15, 2025
pulisher
Apr 15, 2025

Boris Johnson | Biography, Facts, Resignation, & Role in Brexit - Britannica

Apr 15, 2025
pulisher
Apr 14, 2025

The Rock to co-author true crime book about Hawaii mob boss to be adapted by Martin Scorsese - The Guardian

Apr 14, 2025
pulisher
Apr 14, 2025

What I’m Hearing on Shedeur Sanders and Will Johnson. Plus, Offensive Line Tiers, Comps, and Tape Study. - The Ringer

Apr 14, 2025
pulisher
Apr 14, 2025

Mike Johnson opens the door to Medicaid cuts and the resulting political fallout - MSN

Apr 14, 2025
pulisher
Apr 14, 2025

Depot After Dark: Franco In College, Diontae Johnson Praises Big Ben, Steelers Germany Flag Football Camp - Steelers Depot

Apr 14, 2025
pulisher
Apr 14, 2025

Rep. Josh Gottheimer Sells Off Shares of Johnson & Johnson (NYSE:JNJ) - MarketBeat

Apr 14, 2025
pulisher
Apr 14, 2025

Denison, Reigning D3 Men’s NCAA Champion, Add Nicholas Johnson For Fall 2025 - SwimSwam

Apr 14, 2025
$172.99
price up icon 0.76%
drug_manufacturers_general NVO
$58.08
price down icon 7.63%
drug_manufacturers_general NVS
$110.86
price up icon 1.17%
drug_manufacturers_general MRK
$78.00
price up icon 2.01%
$277.29
price down icon 1.89%
Capitalizzazione:     |  Volume (24 ore):